T cell activation markers and methods for evaluating T cell activation

JP2026521344APending Publication Date: 2026-06-30JUNO THERAPEUTICS INC

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
JUNO THERAPEUTICS INC
Filing Date
2024-05-22
Publication Date
2026-06-30

Smart Images

  • Figure 2026521344000001_ABST
    Figure 2026521344000001_ABST
Patent Text Reader

Abstract

This disclosure relates to a method for evaluating the activation state of T cells in a cell composition that may be used in connection with cell therapy, or to a method for generating cells for cell therapy. The cells in the cell composition may express recombinant receptors, such as chimeric receptors, such as chimeric antigen receptors (CARs), or other transgenic receptors such as T cell receptors (TCRs). The method provides markers and methods for using them to evaluate the activation of T cells in a cell composition.
Need to check novelty before this filing date? Find Prior Art